Limited access to new treatments and slow research pipelines in Britain are pushing patients to take financial risks to fund therapies that they have discovered online
Notifications can be managed in browser preferences.
Swipe for next article
Limited access to new treatments and slow research pipelines in Britain are pushing patients to take financial risks to fund therapies that they have discovered online
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Neuroendocrine cancer impacts more than 6,000 people a year in England
It’s being called a ‘backward step for NHS care’
One teenager in Wales was forced to travel four to six hours away to get vital cancer treatment, Macmillcan Cancer Support…
Exclusive: Drugs to treat stroke and schizophrenia patients could be hit if suppliers no longer see them as commercially viable
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Researchers found children with Neuroblastoma had lower survival rates in the UK and Ireland compared with other countries in…
